TABLE 2

Comparison between physiological effects of noninvasive ventilation (NIV) and high-flow nasal cannula (HFNC)

NIVHFNCHFNC–NIV
Median (IQR)Median (IQR)Median (95% CI)p-value#
VT global (units)3161 (1884–3805)2323 (1497–2891)−678.0 (−947.5– −322.0)0.001
VT ROI1 (units)887 (657–1033)590 (464–774)−204.5 (−279.5– −122.0)0.0007
VT ROI2 (units)686 (413–925)445 (262–656)−214.0 (−309.0– −130.0)0.0003
VT ROI3 (units)743 (498–1008)589 (271–909)−118.5 (−221.5–0.0)0.04
VT ROI4 (units)444 (318–861)450 (286–664)−93.5 (−200.0–7.5)0.06
VT consolidation (units)778 (338–1002)489 (198–783)−133.0 (−215.0– −53.5)0.004
EELI global (units)4083 (2928–5134)2921 (1706–4850)−570.5 (−1649.5–824.0)0.4
EELI ROI1 (units)842 (646–1144)562 (215–1000)−329.0 (−570.5– −110.0)0.01
EELI ROI2 (units)960 (469–1406)408 (355–1152)−174.0 (−563.0–79.5)0.1
EELI ROI3 (units)767 (336–1124)618 (370–1251)−101.0 (−487.0–476.0)0.5
EELI ROI4 (units)846 (488–971)447 (373–738)−196.0 (−491.5–733.0)0.4
EELI consolidation (units)899 (767–1144)486 (381–946)−322.5 (−588.5–178.5)0.1
Respiratory rate (breaths·min−1)24 (22–27)23 (21–26)−2 (−4–4)0.6
SpO2/FiO2 ratio167 (143–200)163 (140–200)−4.5 (−15.5– −2.0)0.001
SpO2 (%)100 (98–100)97 (96–100)−2 (−3–0)0.010
Heart rate (beats·min−1)84 (68–98)90 (78–104)1 (−2–5)0.8
SBP (mmHg)119 (108–131)125 (113–137)3 (−1–11)0.2
MAP (mmHg)80 (76–89)85 (77–94)2 (−3–5)0.6
Dyspnoea score (0–10)5 (0–5)5 (2–5)0 (−1–1)0.7
Patient comfort score (0–10)4 (2–5)5 (4–7)0 (−1–4)0.7

Bold type represents statistical significance. IQR: interquartile range; VT: tidal volume variation; ROI: region of interest; EELI: end-expiratory lung impedance; SpO2: pulse oxygen saturation; FiO2: inspiratory oxygen fraction; SBP: systolic blood pressure; MAP: mean arterial pressure. #: Wilcoxon signed rank test.